openPR Logo
Press release

Mobile Applications for Melanoma Detection Market Size will Exceed more than US$ 1.5 Million by 2022

10-09-2017 10:06 AM CET | IT, New Media & Software

Press release from: (MRE) Report

Mobile Applications for Melanoma Detection Market

Mobile Applications for Melanoma Detection Market

Prospects of Mobile Applications for Melanoma Detection in the International Market

It is estimated that the Mobile Applications for Melanoma Detection market will grow more than USD$ 1.5 million by 2022 and the CAGR in Israel and Europe is expected to raise up to 46.5 percent. The reason behind the growth of this market is the increase in the number of Melanoma or skin cancer. Increase usage of mHealth through Smartphone and cost effectiveness also contributes in the growth of Mobile Applications for Melanoma Detection industry. However, accuracy and costly regulation procedures are the two factors restraining the growth of this industry.

For additional information on the subject visit the following link: https://www.marketresearchengine.com/reportdetails/mobile-applications-for-melanoma-detection-market

Key Players of Mobile Applications For Melanoma Detection Market

Leading key players of Mobile Applications For Melanoma Detection Market are DermaCompare, DermLink.MD, FotoSkin, iDoc24, Melanoma iABCD rule, MoleQuest, Skin Cancer, Mole Monitor, MelApp, Mole Checker (Stroika), Skin Of Mine, Nevus OnlineDermClinic, LoveMySkin, Dermatology Planet, Skin Tagger, ABCDEs of Melanoma, Melanoma Calculator, Skin Prevention, Skin MD Now, SkinVision, Mole Doctor Skin Cancer App Dermatologist, SpotCheck, Skin Mole Analysis, Doctor Mole, iSkin, Melanoma Visual Risk Calculator, UMSkinCheck, Mole Check, SpotMole Plus, Melanoma Watch, Mole Checker, Skin Doctor, YourSkinDiary, Skin Analytics, Mole Trac, Mollie’s Fund, Skin Tagger, Mollie’s Fund, SPOT IT & NAME IT, Skin Scanner, Track-A-Mole and SpotMole

Segmentation in the Mobile Applications for Melanoma Detection Market

The mobile applications for melanoma detection market can be segmented based on geographical regions, such as Europe, Latin America, Africa, North America, Middle East and Asia Pacific. Each of these mentioned regions are further segmented for generating revenues for other regions like Canada, India, Germany, Brazil, Japan, China and some of the GCC countries.

Melanoma is a type of skin cancer, in this condition cells producing melanin multiply rapidly. Melanin is a pigment that provides color to skin. This occurs mainly in eyes; skin and at times even on the internal also the problem is very common in women than in men. Young people are more prone to this problem than older ones. If the symptom of this skin cancer is detected in the early stage then it can be treated and spreading of cancer across the skin is prevented. Symptoms of melanoma can be identified by experts either by screening or skin surveillance. Self screen is also an effective way to diagnose symptoms of melanoma. Use of various mobile applications actually helps in enhancing the accuracy of patients self screening, which in turn decreases the mortality rate to a considerable extent. The application guides the user on how to identify skin changes or how to analyze moles, lesion and take picture of doubtful moles. Further, the application also provides information on the ways to prevent skin cancer.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/mobile-applications-for-melanoma-detection-market

Mobile Applications for Melanoma Detection Report Offers a Study of Global and Regional Markets

The report on Mobile Applications for Melanoma Detection Market gives a detail summary of Mobile Applications for Melanoma Detection Market and similar technology in the market. Provides deep analysis of market trend and also forecast of CAGRs by 2022. Helps in identifying new opportunities and also glance on the demand for new products or applications.


Table of Contents

1 INTRODUCTION
2 Executive Summary
3 Global IT-enabled Healthcare Market Overview
4 Global IT-enabled Healthcare Software Market, by Type
4.1 Overview
4.1.1 Comparative Analysis: IT-enabled Healthcare Software Market Revenue, by Type, 2013 & 2020 (Value %)
4.2 Healthcare System Applications
4.2.1 Administrative Information Systems (AIS)
4.2.2 Clinical Information Systems (CIS)
4.2.2.1 Electronic Medical Record (EMR)
4.2.2.2 Nursing Information Systems (NIS)
4.2.2.3 Computer Aided Diagnosis (CAD)
4.2.2.4 Others (Medical Imaging and Surgery Training and so on)
4.2.3 Ancillary Information Systems
4.2.3.1 Pharmacy Information Systems (PIS)
4.2.3.2 Laboratory Information Systems (LIS)
4.3 mHealth Applications (Solutions for Patients)
5 Global IT-enabled Healthcare Services Market, by Type
6 Global IT-enabled Healthcare Market, by End-user
7 Global IT-enabled Healthcare Market, By Geography
8 Company Profiles
8.1 McKesson Corporation
8.2 eHealth Technologies
8.3 GE Healthcare
8.4 Johnson and Johnson Healthcare Systems, Inc.
8.5 Aerotel Medical Systems, Ltd.
8.6 Siemens AG
8.7 Allscripts Healthcare Solutions, Inc.
8.8 E*HealthLine.Com, Inc.
8.9 AT&T Inc.
8.10 Apple, Inc.
8.11 AirStrip Technologies LP
8.12 Cerner Corporation
8.13 IMS Health Holdings, Inc.
8.14 Koninklijke Philips N.V.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mobile Applications for Melanoma Detection Market Size will Exceed more than US$ 1.5 Million by 2022 here

News-ID: 762171 • Views:

More Releases from (MRE) Report

Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018: Weight Management Market 2018 The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018: Home Healthcare Market 2018 The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018: Healthcare 3D Printing Market 2018 The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018: Tumor Ablation Market 2018 The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed

All 5 Releases


More Releases for Melanoma

Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period? The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market? The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market? The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: • Pfizer Inc. • Bristol-Myers Squibb Company • Abbott Laboratories • Amgen, Inc. • Merck & Co., Inc. • Novartis AG • F. Hoffmann-La Roche Ltd • Sanofi S.A. • Qiagen NV • Sun Pharmaceutical Industries Ltd
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic